Advertisement
GKOS vs MLSS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a Hold and MLSS is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GKOS’s FA Score shows that 0 FA rating(s) are green whileMLSS’s FA Score has 0 green FA rating(s).
- GKOS’s FA Score: 0 green, 5 red.
- MLSS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GKOS’s TA Score shows that 3 TA indicator(s) are bullish while MLSS’s TA Score has 3 bullish TA indicator(s).
- GKOS’s TA Score: 3 bullish, 5 bearish.
- MLSS’s TA Score: 3 bullish, 5 bearish.
Price Growth
GKOS (@Medical/Nursing Services) experienced а -7.48% price change this week, while MLSS (@Pharmaceuticals: Other) price change was -12.87% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.25%. For the same industry, the average monthly price growth was -0.64%, and the average quarterly price growth was +13.10%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.79%. For the same industry, the average monthly price growth was -0.75%, and the average quarterly price growth was +22.77%.
Reported Earning Dates
GKOS is expected to report earnings on Feb 17, 2026.
MLSS is expected to report earnings on Mar 27, 2026.
Industries' Descriptions
@Medical/Nursing Services (-3.25% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-1.79% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| GKOS | MLSS | GKOS / MLSS | |
| Capitalization | 6.59B | 20M | 32,930% |
| EBITDA | -42.92M | -6.49M | 661% |
| Gain YTD | 1.559 | -6.996 | -22% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 470M | 8.93M | 5,263% |
| Total Cash | 274M | 1.35M | 20,372% |
| Total Debt | 104M | 1.05M | 9,867% |
GKOS | MLSS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 71 | 100 | |
SMR RATING 1..100 | 95 | 99 | |
PRICE GROWTH RATING 1..100 | 45 | 91 | |
P/E GROWTH RATING 1..100 | 61 | 100 | |
SEASONALITY SCORE 1..100 | 90 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GKOS's Valuation (93) in the Medical Specialties industry is in the same range as MLSS (98). This means that GKOS’s stock grew similarly to MLSS’s over the last 12 months.
GKOS's Profit vs Risk Rating (71) in the Medical Specialties industry is in the same range as MLSS (100). This means that GKOS’s stock grew similarly to MLSS’s over the last 12 months.
GKOS's SMR Rating (95) in the Medical Specialties industry is in the same range as MLSS (99). This means that GKOS’s stock grew similarly to MLSS’s over the last 12 months.
GKOS's Price Growth Rating (45) in the Medical Specialties industry is somewhat better than the same rating for MLSS (91). This means that GKOS’s stock grew somewhat faster than MLSS’s over the last 12 months.
GKOS's P/E Growth Rating (61) in the Medical Specialties industry is somewhat better than the same rating for MLSS (100). This means that GKOS’s stock grew somewhat faster than MLSS’s over the last 12 months.
| GKOS | MLSS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 73% | 1 day ago 82% |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 62% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 90% |
| Advances ODDS (%) | 15 days ago 76% | 14 days ago 77% |
| Declines ODDS (%) | 23 days ago 68% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 75% | 1 day ago 90% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICRNX | 10.40 | 0.10 | +0.97% |
| VY® CBRE Global Real Estate A | |||
| UPMMX | 54.11 | 0.15 | +0.28% |
| Victory Precious Metals & Minerals Cl A | |||
| ABVIX | 19.40 | 0.04 | +0.21% |
| AB Large Cap Value I | |||
| TRWFX | 26.85 | 0.05 | +0.19% |
| Transamerica International Equity R4 | |||
| CNPEX | 68.94 | -0.38 | -0.55% |
| American Funds New Perspective 529E | |||
GKOS and
Correlation & Price change
A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with GMED. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then GMED could also see price increases.
| Ticker / NAME | Correlation To GKOS | 1D Price Change % | ||
|---|---|---|---|---|
| GKOS | 100% | -2.94% | ||
| GMED - GKOS | 60% Loosely correlated | -0.45% | ||
| PEN - GKOS | 58% Loosely correlated | -4.52% | ||
| CERS - GKOS | 53% Loosely correlated | -2.14% | ||
| ISRG - GKOS | 51% Loosely correlated | -0.08% | ||
| IRMD - GKOS | 51% Loosely correlated | -4.22% | ||
More | ||||
MLSS and
Correlation & Price change
A.I.dvisor indicates that over the last year, MLSS has been loosely correlated with NXGL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MLSS jumps, then NXGL could also see price increases.
| Ticker / NAME | Correlation To MLSS | 1D Price Change % | ||
|---|---|---|---|---|
| MLSS | 100% | -4.55% | ||
| NXGL - MLSS | 48% Loosely correlated | -0.81% | ||
| STVN - MLSS | 48% Loosely correlated | +1.00% | ||
| SMTI - MLSS | 47% Loosely correlated | +0.92% | ||
| STXS - MLSS | 42% Loosely correlated | -4.13% | ||
| ZJYL - MLSS | 39% Loosely correlated | +1.45% | ||
More | ||||